Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-04-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of tDCS Over the Cerebellum on Motor Function
NCT00413842
Effects of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Refractory Epilepsy
NCT04325360
Neurophysiological Study of tDCS Effects in Healthy Volunteers
NCT02125422
Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial
NCT02122237
Comparing Transcranial Direct Current Stimulation Montages in Stroke
NCT04340973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anodal tDCS
anaodal transcranial direct current stimulation
Anodal tDCS
Cathodal tDCS
cathodal transcranial direct current stimulation
Cathodal tDCS
Sham tDCS
no stimulation
sham tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anodal tDCS
Cathodal tDCS
sham tDCS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. NOTCH3 carrier
3. Migraine with aura (IHS Classification ICHD-II)
4. Stenosis \>80%, ECST-Criteria
Exclusion Criteria
* history of severe alcohol or drug abuse, psychiatric illness like severe depression, poor motivational capacity
* dementia
(1+2) history of stroke in past 3 months (3) migraine prophylaxis (4) contralateral stenosis \>50%,
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Agnes Flöel
Prof. Dr. med. Agnes Floeel
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Agnes Flöel, Prof. MD
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology, Charité Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
tDCS_cVMR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.